Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Twin Disc (NASDAQ:TWIN) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Twin Disc will report an earnings per share (EPS) of $0.05.

Benzinga

Analyst Ratings for Plains GP Holdings

Analysts have provided the following ratings for Plains GP Holdings (NASDAQ:PAGP) within the last quarter:

Benzinga

WisdomTree Investments's Earnings Outlook

WisdomTree Investments (NASDAQ:WETF) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that WisdomTree Investments will report an earnings per share (EPS) of $0.08.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What 6 Analyst Ratings Have To Say About Arvinas

Over the past 3 months, 6 analysts have published their opinion on Arvinas (NASDAQ:ARVN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Piper Sandler Maintains Overweight Rating for Amgen: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Amgen (NASDAQ:AMGN) and raise its price target from $255.00 to $260.00. Shares of Amgen are trading down 5.5% over the last 24 hours, at $235.12 per share. A move to $260.00 would account for a 10.58% increase from the current…

Benzinga

Earnings Preview: Virtus Investment

Virtus Investment (NASDAQ:VRTS) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Virtus Investment will report an earnings per share (EPS) of $7.90.

Benzinga

Wells Fargo Maintains Equal-Weight Rating for Qualcomm: Here's What You Need To Know

Wells Fargo has decided to maintain its Equal-Weight rating of Qualcomm (NASDAQ:QCOM) and lower its price target from $185.00 to $150.00. Shares of Qualcomm are trading up 6.49% over the last 24 hours, at $143.87 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings for Kymera Therapeutics

Kymera Therapeutics (NASDAQ:KYMR) has observed the following analyst ratings within the last quarter:

Benzinga

This Is What Whales Are Betting On Align Tech

Someone with a lot of money to spend has taken a bearish stance on Align Tech (NASDAQ:ALGN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Earnings Outlook For Cowen

Cowen (NASDAQ:COWN) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Cowen will report an earnings per share (EPS) of $0.79.

Benzinga

If You Invested $1000 In Qualcomm 5 Years Ago, Here's How Much You Would Have Today

Qualcomm (NASDAQ:QCOM) has outperformed the market over the past 5 years by 10.01% on an annualized basis producing an average annual return of 21.97%. Currently, Qualcomm has a market capitalization of $162.07 billion.

Benzinga

Raymond James Maintains Outperform Rating for Hologic: Here's What You Need To Know

Raymond James has decided to maintain its Outperform rating of Hologic (NASDAQ:HOLX) and lower its price target from $84.00 to $83.00. Shares of Hologic are trading down 2.08% over the last 24 hours, at $69.37 per share. A move to $83.00 would account for a 19.65% increase from the current…

Benzinga

BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy

BioMarin Pharmaceutical Inc's (NASDAQ:BMRN) Q1 sales reached $519 million, up 7% Y/Y, beating the consensus of $507.52 million. BioMarin said that the increase was achieved "despite continued erosion of the U.S. Kuvan market." Kuvan is indicated for phenylketonuria. Kuvan still brought in $59.3 million but down from $70.8 million a year ago.…

Benzinga

Dupixent, Consumer Healthcare Lifts Sanofi's Q1 Earnings, Backs FY22 Guidance

Sanofi SA (NASDAQ:SNY) posted a net profit of €2 billion for Q1 FY22, up from €1.57 billion a year ago. Sales reached €9.67 billion, up from €8.59 billion in Q1 FY21. Eczema drug, Dupixent, and consumer healthcare drove the growth. Dupixent alone grew by 45.7% to €1.6 billion, driving Sanofi's specialty care…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cathie Wood's ARK Innovation ETF Hits 52-Week Low: What's Going On?

ARK Innovation ETF (ARCA:ARKK) is making new 52-week lows on Thursday, led by sharp declines in the top holdings of Ark's flagship fund.

Benzinga

Here's How Much You Would Have Made Owning AMD Stock In The Last 5 Years

Advanced Micro Devices (NASDAQ:AMD) has outperformed the market over the past 5 years by 41.08% on an annualized basis producing an average annual return of 53.09%. Currently, Advanced Micro Devices has a market capitalization of $141.23 billion.

Benzinga

$100 Invested In Google 15 Years Ago Would Be Worth This Much

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 15 years by 9.41% on an annualized basis producing an average annual return of 16.49%. Currently, Alphabet has a market capitalization of $1.54 trillion.

Benzinga

Allegiance Bancshares Earnings Preview

Allegiance Bancshares (NASDAQ:ABTX) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Allegiance Bancshares will report an earnings per share (EPS) of $0.82.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Analyst Ratings for Aurinia Pharmaceuticals

Analysts have provided the following ratings for Aurinia Pharmaceuticals (NASDAQ:AUPH) within the last quarter:

Benzinga

Earnings Preview: Balchem

Balchem (NASDAQ:BCPC) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Balchem will report an earnings per share (EPS) of $0.82.

Benzinga

LKQ Q1 Earnings Top Estimates; Raises FY22 Outlook

LKQ Corp (NASDAQ:LKQ) reported first-quarter FY22 sales growth of 5.6% year-on-year to $3.35 billion, marginally above the consensus of $3.30 billion. Revenue in North America rose 14.2% Y/Y, and Europe increased 1.8%. Gross margin for the quarter compressed 30 basis points Y/Y to 40.5%. Operating margin contracted 60 basis points to 11.1%, and…

Benzinga

Recap: First of Long Island Q1 Earnings

First of Long Island (NASDAQ:FLIC) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Carlyle Group Q1 Earnings

Carlyle Group (NASDAQ:CG) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Summit Finl Q1 Earnings

Summit Finl Gr (NASDAQ:SMMF) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

Towne Bank: Q1 Earnings Insights

Towne Bank (NASDAQ:TOWN) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

1 … 544 545 546 547

People

Cathie Wood

605 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.